Personalizing Treatment of Early-Stage Breast Cancer
Emiel J. Rutgers, MD, from the Netherlands Cancer Institute, describes the personalization of treatment for patients with early-stage breast cancer.
Emiel J. Rutgers, MD, surgical oncologist, Netherlands Cancer Institute, Amsterdam, describes the personalization of treatment for patients with early-stage breast cancer.
Clinical Pearls
In this group of patients, a physician must look at the results of a sentinel node biopsy and consider the primary tumor characteristics. If there is low tumor involvement, a physician would most likely determine that no treatment of the axial is adequate. If a patient has more tumor involvement in the sentinel nodes and larger tumor burden in the breast, elective treatment of the axilla with radiotherapy is a good strategy.
- In patients with low tumor involvement, no treatment of the axilla is adequate
- In patients with more tumor involvement in the sentinel nodes, elective treatment of the axilla with radiotherapy is a good strategy
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More
